Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test”

• Thomas Weiland,
• Luka Brcic,
• Markus Reinholz,
• Lars E. French,
• Dietmar Thurnher

Affiliations

Thomas Weiland

Department of Otorhinolaryngology-Head&Neck Surgery, Medical University of Graz, Graz, Austria; Corresponding author.

Luka Brcic

Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria

Markus Reinholz

Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany

Lars E. French

Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany

Dietmar Thurnher

Department of Otorhinolaryngology-Head&Neck Surgery, Medical University of Graz, Graz, Austria